Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

US star Ilia Malinin defended his world figure skating title on Saturday with a dominant display on the ice inside Boston’s packed TD Garden. In truth, Malinin simply made official what many ...

I apologize.” The actress also opened up about how she stays in shape but admitted she doesn’t need to work out to maintain her enviable figure. “Four times a year, I put music on and walk ...

As it unfurls, the saga of Mahmoud Khalil—the Columbia agitator picked up by immigration enforcement last week—looks less like a complicated immigration-law dispute and more like something out of a ...

NBC Sports and Peacock combine to air every major event of the 2024-25 figure skating season, from the Grand Prix Series that started in October through the World Team Trophy in April. The next and ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other stocks that Jim Cramer discusses. On Thursday, April 3rd, the host of ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Goldman Sachs projects the humanoid robot market to reach $38 billion by 2035. Figure AI, valued at $2.6 billion, recently raised $675 million in a Series B funding round. DFigure AI is not ...